MARC Record from harvard_bibliographic_metadata

LEADER: 06911cam a2200469 a 4500
001 013508600-0
005 20121206121903.0
008 120119s2012 enka b 001 0 eng
010 $a 2012002558
015 $aGBB212739$2bnb
016 7 $a101576567$2DNLM
016 7 $a016026780$2Uk
020 $a9781444338225 (hardcover : alk. paper)
020 $a1444338226 (hardcover : alk. paper)
035 0 $aocn773811680
040 $aDNLM/DLC$beng$cDLC$dYDX$dNLM$dBDX$dYDXCP$dCDX$dYNK$dUKMGB$dOCLCO
042 $apcc
050 04 $aRC694.5.I53$bI54 2012
060 00 $a2012 G-238
060 10 $aWG 515
082 00 $a616.1/3$223
245 00 $aInflammatory diseases of blood vessels /$cedited by Gary S. Hoffman ... [et al.].
250 $a2nd ed.
260 $aChichester, West Sussex ;$aHoboken, NJ :$bWiley-Blackwell,$c2012.
300 $axiv, 582 p. :$bill. (chiefly col.) ;$c26 cm.
504 $aIncludes bibliographical references and index.
500 $aMachine generated contents note: List of Contributors Preface Section I. Biology of Blood Vessels and Mechanisms of Vascular Inflammation 1. Vascular Development Domenico Ribatti and Enrico Crivellato 2. Vascular Repair Christian Troidl, Kerstin Troidl, Georg Jung, Thomas Schmitz-Rixen and Wolfgang Schaper 3. Leukocyte Trafficking Braedon McDonald and Paul Kubes 4. Dendritic Cells and Vascular Inflammation Cornelia M. Weyand 5. T Cells and Vascular Inflammation Jörg J. Goronzy 6. Autoantibodies and Vascular Inflammation A. Rutgers, J.S.F. Sanders, J.W. Cohen Tervaert, C.G.M. Kallenberg 7. Neutrophils and Vascular Inflammation Matthew David Morgan and Caroline OS Savage 8. Cytokines and Vascular Inflammation Maria C Cid, Marc Corbera-Bellalta, Ester Planas-Rigol, Ester Lozano, Georgina Espigol-Frigole, Ana Garcia-Martinez, Jose Hernández-Rodriguez, Marta Segarra 9. Oxidative Stress and Vascular Inflammation David G. Harrison 10.
500 $aHemostasis and Vascular Inflammation Lawrence Leung and John Morser 11. Animal Models of Vasculitis Masato Nose 12. Arteries, Smooth Muscle Cells, and Genetic Causes of Thoracic Aortic Aneurysms Amy J. Reid and Dianna M. Milewicz 13. Innate Immunity in Atherosclerosis Shuang Chen, Prediman K. Shah and Moshe Arditi 14. Adaptive Immunity in Atherosclerosis Jan Nilsson Section II. Primary Autoimmune Vascular Diseases 15. Historical Perspectives Vasculitis Eric L. Matteson 16. Approach to the Differential Diagnosis of Vasculitis Eamonn S. Molloy and Carol A. Langford 17. Imaging of medium and large vessels (CT/PET/MR) Thorsten Alexander Bley 18. Kawasaki disease Rae S.M. Yeung 19. Henoch-Schonlein Purpura Philip J. Hashkes and Alexandra Villa-Forte 20. Polyarteritis Nodosa Eli M. Miloslavsky and John H. Stone 21. Microscopic polyangiitis Coen Stegeman 22 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Gary S. Hoffman, Carol A. Langford and Ulrich Specks 23.
500 $aChurg-Strauss Syndrome (Eosinophilic Granulomatosis with Polyangiitis, EGPA) Christian Pagnoux and Loic Guillevin 24. Giant cell arteritisCornelia M. Weyand and Jörg J. Goronzy 25. Takayasu's arteritis Kathleen Maksimowicz-McKinnon and Gary S. Hoffman 26. Behçet's Syndrome Yusuf Yazici, Ismail Simsek and Hasan Yazici 27. Cogan's Syndrome Rex M. McCallum and E. William St. Clair 28. Idiopathic cryoglobulinemic vasculitides Benjamin Terrier and Patrice Cacoub 29. Primary central nervous system vasculitis Rula A. Hajj-Ali and Leonard H. Calabrese 30. Single organ vasculitis Jose Hernández-Rodriguez and Gary S. Hoffman 31. Primary cutaneous vasculitis Jeffrey P. Callen 32. Buerger's disease (thromboangiitis obliterans) Ahmet Ruchan Akar and M. Serkan Durdu Section III. Secondary Causes of Vasculitis 33. Virus-associated vasculitides Dimitrios Vassilopoulos and Leonard H. Calabrese 34. Drug-induced vasculitis Peter A. Merkel 35. Rheumatoid vasculitis Kimberly P.
500 $aLiang, Carl Turesson, Larry W. Moreland 36. Vasculopathy/Vasculitis and progressive systemic sclerosis Nezam Altorok, Omar R. Kahaly and Bashar Kahaleh 37. Vasculitis and Sjögren's syndrome George E. Fragoulis and Haralampos M. Moutsopoulos 38. Vasculitis in systemic lupus erythematosus Ricardo Garcia and Andras Perl 39. Vasculitis in the Idiopathic Inflammatory Myopathies Frederick W. Miller and Chester V. Oddis 40. Vasculitis and relapsing polychondritis Tanaz A. Kermani and Kenneth J. Warrington 41. Systemic Vasculitis in Sarcoidosis Alexandra Villa-Forte and Gary S. Hoffman 42. Vasculitis as a Paraneoplastic Syndrome and Direct Tumour Invasion of Vessels Claire E. Barber and Simon Carette Section IV. Recognizing Risks and Treating Damage from Vasculitis 43. Cholesterol and Modifications of Cholesterol in Rheumatic Disorders Jan Willem Cohen Tervaert 44. Prevention and treatment of medical complications Atul Khasnis and Carol A. Langford 45.
500 $aOphthalmic Risks and Complications Associated with the Treatment of Systemic Vasculitis Steven Yeh and James T. Rosenbaum 46. Subglottic Stenosis of Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Rahul Seth and Daniel S. Alam 47. Sino-Nasal Manifestations of Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Daniel S. Alam, Rahul Seth, Raj Sindwani 48. Neurologic Damage of Vasculitis C. David Lin 49. Endstage Renal Disease and Vasculitis Kirsten de Groot and Charles Pusey 50. Cardiothoracic Surgery for Takayasu's Arteritis and Giant Cell ArteritisTurki Albacker and Lars Svensson 51. Peripheral Vascular Surgery for Takayasu's Arteritis and Giant Cell Arteritis Ravi R. Rajani and Vikram S. KashyapIndex.
520 $a"In recent years, considerable progress has been made in understanding the vasculitic diseases, largely due to the introduction of effective treatments for diseases that were once uniformly fatal, the conduct of structured clinical studies, and advances in immunology and molecular biology. Despite these achievements, the vasculitic diseases continue to be associated with morbidity and mortality from chronic organ damage, relapses, and the side effects of treatment. Investigations into the mechanisms of vascular inflammation may lead to a better comprehension of the pathogenesis of vasculitic diseases and to treatment that is more effective and less toxic. These areas of promising research, together with current knowledge about the vasculitic diseases, are extensively examined in this new edition, which is designed to provide a comprehensive overview of the science and clinical consequences of vascular inflammation in health and disease"--Provided by publisher.
650 0 $aVasculitis.
650 0 $aArteritis.
650 12 $aVasculitis.
650 22 $aArteriosclerosis.
650 22 $aImmunologic Factors.
650 22 $aVascular Diseases$ximmunology.
700 1 $aHoffman, Gary S.,$d1942-
988 $a20121206
049 $aHMSS
906 $0OCLC